Tralokinumab, CAS 1044515-88-9

Product Description: Tralokinumab, a fully human IgG4 monoclonal antibody, specifically binds with high affinity to IL-13 alone, preventing its interaction with the receptor and subsequent downstream signalling. Tralokinumab can be used for the research of the atopic dermatitis (AD)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]A Wollenberg, et al. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021 Mar;184(3):437-449.

CAS Number: 1044515-88-9

Molecular Weight: N/A

Compound Purity: 97.59

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• Artikelnummer: MEXHY-P99053-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99053-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK